In medicine, tools are increasingly being use to predict a patient’s symptom progression, identify individuals at risk, or to estimate the response...
On World Cancer Research Day, 24 September, we would like to highlight some of the most significant advances made over the past year by Clínic-IDIB...
The EPoS II study, published in the New England Journal of Medicine, provides new evidence on the follow-up of patients after the removal of high-r...
A study led by Hospital Clínic-IDIBAPS sheds light on how this rare type of lymphoma evolves and why some tumor cells eventually outcompete others.
A study led by professionals from the Clínic-IDIBAPS and the Barcelona Esquerra Primary Healthcare Consortium (CAPSBE) has developed a system for t...
Two international phase 3 clinical trials show that a new treatment significantly improves the ability to stay awake during the day and reduces epi...
A study led by the Clínic-IDIBAPS provides new clues about the genetic basis of psychotic disorders such as schizophrenia and bipolar disorder. Th...
A study published in The European Journal of Health Economics shows that kidney transplant patients can continue their recovery at home, under medi...
The Clínic-IDIBAPS has led the development of EBI-BD, a new open-access, interactive web platform that synthesizes all the available scientific evi...
Thomas Walle, head of the IDIBAPS Computational cancer biomedicine group has received a Starting Grant from the European Research Council (ERC) in...
